Pharmacokinetics, tissue distribution and safety of gold nanoparticle/PKC Delta inhibitor peptide hybrid in rats

References

• Bergen, J. M., H. A. VON Recum, T. T. Goodman, A. P. Massey, and S. H. Pun. 2006. “Gold Nanoparticles as a Versatile Platform for Optimizing Physicochemical Parameters for Targeted Drug Delivery.” Macromolecular Bioscience 6 (7): 506–516. doi:10.1002/mabi.200600075.
   PubMed Web of Science ®Google Scholar
• Cho, W. S., M. J. Cho, J. Jeong, M. Choi, H. Y. Cho, B. S. Han, S. H. Kim, et al. 2009. “Acute Toxicity and Pharmacokinetics of 13 nm-Sized PEG-Coated Gold Nanoparticles.” Toxicology and Applied Pharmacology 236 (1): 16–24. doi:10.1016/j.taap.2008.12.023.
   PubMed Web of Science ®Google Scholar
• Cho, W. S., M. Cho, J. Jeong, M. Choi, B. S. Han, H. S. Shin, J. Hong, B. H. Chung, J. Jeong, and M. H. Cho. 2010. “Size-Dependent Tissue Kinetics of PEG-Coated Gold Nanoparticles.” Toxicology and Applied Pharmacology 245 (1): 116–123. doi:10.1016/j.taap.2010.02.013.
   PubMed Web of Science ®Google Scholar
• Connor, E. E., J. Mwamuka, A. Gole, C. J. Murphy, and M. D. Wyatt. 2005. “Gold Nanoparticles Are Taken up by Human Cells but Do Not Cause Acute Cytotoxicity.” Small 1 (3): 325–327. doi:10.1002/smll.200400093.
   PubMed Web of Science ®Google Scholar
• DE Jong, W. H., W. I. Hagens, P. Krystek, M. C. Burger, A. J. Sips, and R. E. Geertsma. 2008. “Particle Size-Dependent Organ Distribution of Gold Nanoparticles after Intravenous Administration.” Biomaterials 29 (12): 1912–1919. doi:10.1016/j.biomaterials.2007.12.037.
   PubMed Web of Science ®Google Scholar
• Elahi, N., M. Kamali, and M. H. Baghersad. 2018. “Recent Biomedical Applications of Gold Nanoparticles: A Review.” Talanta 184: 537–556. doi:10.1016/j.talanta.2018.02.088.
   PubMed Web of Science ®Google Scholar
• Fischer, H. C., S. Fournier-Bidoz, K. S. Pang, and W. C. W. Chan. 2007. “Quantitative Detection of Engineered Nanoparticles in Tissues and Organs: An Investigation of Efficacy and Linear Dynamic Ranges Using ICP-AES.” Nanobiotechnology 3 (1): 46–54. doi:10.1007/s12030-007-0006-2.
   Google Scholar
• Fraga, S., A. Brandao, M. E. Soares, T. Morais, J. A. Duarte, L. Pereira, L. Soares, et al. 2014. “Short- and Long-Term Distribution and Toxicity of Gold Nanoparticles in the Rat after a Single-Dose Intravenous Administration.” Nanomedicine-Nanotechnology Biology and Medicine 10 (8): 1757–1766. doi:10.1016/j.nano.2014.06.005.
   PubMed Web of Science ®Google Scholar
• Ghosh, P., G. Han, M. DE, C. K. Kim, and V. M. Rotello. 2008. “Gold Nanoparticles in Delivery Applications.” Advanced Drug Delivery Reviews 60 (11): 1307–1315. doi:10.1016/j.addr.2008.03.016.
   PubMed Web of Science ®Google Scholar
• Guerrero, S., J. R. Herance, S. Rojas, J. F. Mena, J. D. Gispert, G. A. Acosta, F. Albericio, and M. J. Kogan. 2012. “Synthesis and in Vivo Evaluation of the Biodistribution of a F-18-Labeled Conjugate Gold-Nanoparticle-Peptide with Potential Biomedical Application.” Bioconjugate Chemistry 23 (3): 399–408. doi:10.1021/bc200362a.
   PubMed Web of Science ®Google Scholar
• Han, B., X. H. Bai, M. Lodyga, J. Xu, B. B. Yang, S. Keshavjee, M. Post, and M. Liu. 2004. “Conversion of Mechanical Force into Biochemical Signaling.” The Journal of Biological Chemistry 279 (52): 54793–54801. doi:10.1074/jbc.M406880200.
   PubMed Web of Science ®Google Scholar
• Han, S. G., J. S. Lee, K. Ahn, Y. S. Kim, J. K. Kim, J. H. Lee, J. H. Shin, et al. 2015. “Size-Dependent Clearance of Gold Nanoparticles from Lungs of Sprague-Dawley Rats after Short-Term Inhalation Exposure.” Archives of Toxicology 89 (7): 1083–1094. doi:10.1007/s00204-014-1292-9.
   PubMed Web of Science ®Google Scholar
• Hirn, S., M. Semmler-Behnke, C. Schleh, A. Wenk, J. Lipka, M. Schaffler, S. Takenaka, et al. 2011. “Particle Size-Dependent and Surface Charge-Dependent Biodistribution of Gold Nanoparticles after Intravenous Administration.” European Journal of Pharmaceutics and Biopharmaceutics 77 (3): 407–416. doi:10.1016/j.ejpb.2010.12.029.
   PubMed Web of Science ®Google Scholar
• Jia, Y. P., B. Y. Ma, X. W. Wei, and Z. Y. Qian. 2017. “The in Vitro and in Vivo Toxicity of Gold Nanoparticles.” Chinese Chemical Letters 28 (4): 691–702. doi:10.1016/j.cclet.2017.01.021.
   Web of Science ®Google Scholar
• Kim, H., J. Zhao, Q. Zhang, Y. Wang, D. Lee, X. Bai, L. Turrell, et al. 2016. “deltaV1-1 Reduces Pulmonary Ischemia Reperfusion-Induced Lung Injury by Inhibiting Necrosis and Mitochondrial Localization of PKCdelta and p53.” American Journal of Transplantation 16 (1): 83–98. doi:10.1111/ajt.13445.
   PubMed Web of Science ®Google Scholar
• Kim, T., K. Lee, M. S. Gong, and S. W. Joo. 2005. “Control of Gold Nanoparticle Aggregates by Manipulation of Interparticle Interaction.” Langmuir 21 (21): 9524–9528. doi:10.1021/la0504560.
   PubMed Web of Science ®Google Scholar
• Konoeda, H., H. Yang, C. Yang, A. Gower, C. Xu, W. Zhang, and M. Liu. 2019. “Protein Kinase C-Delta Inhibitor Peptide Formulation Using Gold Nanoparticles.” Journal of Visualized Experiments (145): e58741. doi:10.3791/58741.
   Web of Science ®Google Scholar
• Kumar, A., X. Zhang, and X. J. Liang. 2013. “Gold Nanoparticles: Emerging Paradigm for Targeted Drug Delivery System.” Biotechnology Advances 31 (5): 593–606. doi:10.1016/j.biotechadv.2012.10.002.
   PubMed Web of Science ®Google Scholar
• Lee, D., J. Zhao, H. Yang, S. Xu, H. Kim, S. Pacheco, S. Keshavjee, and M. Liu. 2015. “Effective Delivery of a Rationally Designed Intracellular Peptide Drug with Gold Nanoparticle-Peptide Hybrids.” Nanoscale 7 (29): 12356–12360. doi:10.1039/C5NR02377G.
   PubMed Web of Science ®Google Scholar
• Lopez-Chaves, C., J. Soto-Alvaredo, M. Montes-Bayon, J. Bettmer, J. Llopis, and C. Sanchez-Gonzalez. 2018. “Gold Nanoparticles: Distribution, Bioaccumulation and Toxicity. In Vitro and in Vivo Studies.” Nanomedicine 14 (1): 1–12. doi:10.1016/j.nano.2017.08.011.
   PubMed Web of Science ®Google Scholar
• Mironava, T., M. Hadjiargyrou, M. Simon, V. Jurukovski, and M. H. Rafailovich. 2010. “Gold Nanoparticles Cellular Toxicity and Recovery: effect of Size, Concentration and Exposure Time.” Nanotoxicology 4 (1): 120–137. doi:10.3109/17435390903471463.
   PubMed Web of Science ®Google Scholar
• Morais, T., M. E. Soares, J. A. Duarte, L. Soares, S. Maia, P. Gomes, E. Pereira, S. Fraga, H. Carmo, and M. D. L. Bastos. 2012. “Effect of Surface Coating on the Biodistribution Profile of Gold Nanoparticles in the Rat.” European Journal of Pharmaceutics and Biopharmaceutics 80 (1): 185–193. doi:10.1016/j.ejpb.2011.09.005.
   PubMed Web of Science ®Google Scholar
• Nativo, P., I. A. Prior, and M. Brust. 2008. “Uptake and Intracellular Fate of Surface-Modified Gold Nanoparticles.” Acs Nano 2 (8): 1639–1644. doi:10.1021/nn800330a.
   PubMed Web of Science ®Google Scholar
• Olmedo, Ivonne, Eyleen Araya, Fausto Sanz, Elias Medina, Jordi Arbiol, Pedro Toledo, Alejandro Álvarez-Lueje, Ernest Giralt, and MarceloJ. Kogan. 2008. “How Changes in the Sequence of the Peptide CLPFFD-NH2 Can Modify the Conjugation and Stability of Gold Nanoparticles and Their Affinity for Beta-Amyloid Fibrils.” Bioconjugate Chemistry 19 (6): 1154–1163. doi:10.1021/bc800016y.
   PubMed Web of Science ®Google Scholar
• Pan, Y., S. Neuss, A. Leifert, M. Fischler, F. Wen, U. Simon, G. Schmid, W. Brandau, and W. Jahnen-Dechent. 2007. “Size-Dependent Cytotoxicity of Gold Nanoparticles.” Small 3 (11): 1941–1949. doi:10.1002/smll.200700378.
   PubMed Web of Science ®Google Scholar
• Sonavane, G., K. Tomoda, and K. Makino. 2008. “Biodistribution of Colloidal Gold Nanoparticles after Intravenous Administration: effect of Particle Size.” Colloids and Surfaces B: Biointerfaces 66 (2): 274–280. doi:10.1016/j.colsurfb.2008.07.004.
   PubMed Web of Science ®Google Scholar
• Takeuchi, I., S. Nobata, N. Oiri, K. Tomoda, and K. Makino. 2017. “Biodistribution and Excretion of Colloidal Gold Nanoparticles after Intravenous Injection: Effects of Particle Size.” Bio-Medical Materials and Engineering 28: 315–323. doi:10.3233/BME-171677.
   PubMed Web of Science ®Google Scholar
• Takeuchi, I., H. Onaka, and K. Makino. 2018. “Biodistribution of Colloidal Gold Nanoparticles after Intravenous Injection: Effects of PEGylation at the Same Particle Size.” Bio-Medical Materials and Engineering 29 (2): 205–215. doi:10.3233/BME-171723.
   PubMed Web of Science ®Google Scholar
• Xiao, H., X. H. Bai, A. Kapus, W. Y. Lu, A. S. Mak, and M. Liu. 2010. “The Protein Kinase C Cascade Regulates Recruitment of Matrix Metalloprotease 9 to Podosomes and Its Release and Activation.” Molecular and Cellular Biology 30 (23): 5545–5561. doi:10.1128/MCB.00382-10.
   PubMed Web of Science ®Google Scholar
• Yang, H., S. Y. Fung, and M. Y. Liu. 2011. “Programming the Cellular Uptake of Physiologically Stable Peptide-Gold Nanoparticle Hybrids with Single Amino Acids.” Angewandte Chemie International Edition 50 (41): 9643–9646. doi:10.1002/anie.201102911.
   PubMed Web of Science ®Google Scholar
• Yang, H., Y. Z. Zhou, S. Y. Fung, L. C. Wu, K. Tsai, R. S. Tan, S. E. Turvey, et al. 2013. “Amino Acid Structure Determines the Immune Responses Generated by Peptide-Gold Nanoparticle Hybrids.” Particle & Particle Systems Characterization 30: 1039–1043. doi:10.1002/ppsc.201300213.
   Web of Science ®Google Scholar
• Yao, L., C. Xu, and M. Liu. 2019. “Safety and Efficacy of Gold Nanoparticle-Based Drug Delivery.” Nanomedicine: Nanotechnology, Biology, and Medicine. Under Review.
   Google Scholar
• Zhang, X. D., D. Wu, X. Shen, P. X. Liu, N. Yang, B. Zhao, H. Zhang, Y. M. Sun, L. A. Zhang, and F. Y. Fan. 2011. “Size-Dependent in Vivo Toxicity of PEG-Coated Gold Nanoparticles.” International Journal of Nanomedicine 6: 2071–2081. doi:10.2147/IJN.S21657.
   PubMed Web of Science ®Google Scholar
• Zhao, M., and M. Liu. 2018. “New Avenues for Nanoparticle-Related Therapies.” Nanoscale Research Letters 13 (1): 136. doi:10.1186/s11671-018-2548-8.
   PubMedGoogle Scholar